Masanobu Shiga

6PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2026
Assessment of Multiple Prognostic Scores in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line, Immune-Based Combinations.

|May 24, 2026
Adrenocortical Carcinoma in Peutz-Jeghers Syndrome With a Rare STK11 Pathogenic Germline Variant: A Case Report.

|May 07, 2026
Impact of European Association of Urology Combination and Platinum Eligibility on Real-World Treatment Sequences and Survival in Japanese Patients With Metastatic Urothelial Carcinoma.

|Jan 24, 2026
Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study.

Takashi Kawahara, Yoshiyuki Nagumo, Akane Yamaguchi

|Sep 05, 2025
Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer.

Bunpei Isoda, Masanobu Shiga, Shuya Kandori

|Jan 03, 2025
The correlation between discrepancies in clinical and pathological T stages and overall survival in upper urinary tract urothelial carcinoma: Analysis of the hospital-based cancer registry data in Japan.

Masanobu Shiga, Yoshiyuki Nagumo, Kosuke Kojo

Pageof 1

Frequent Collaborators

6 joint publications

Shuya Kandori

4 joint publications

Akio Hoshi

3 joint publications

Satoshi Nitta

3 joint publications

Takashi Kawahara